Last updated: November 23, 2021
Sponsor: Beijing Grand Johamu Pharmaceutical Company, Ltd.
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pneumonia
Pneumonia (Pediatric)
Treatment
N/AClinical Study ID
NCT05002192
YD_SMQD_ELP_202009
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with community-acquired pneumonia
- Inpatients from 2017 to 2019
- Regardless of age and gender
Exclusion
Exclusion Criteria:
- Patients diagnosed with hospital-acquired pneumonia
- Patients who take two or more oral mucolytics
- Patients with combined use of Chinese and Western expectorants other than mucolyticdrugs
Study Design
Total Participants: 10000
Study Start date:
September 01, 2020
Estimated Completion Date:
December 31, 2022
Connect with a study center
Peking University Peoples Hospital
Beijing, Beijing 100044
ChinaActive - Recruiting
Guangdong Provincial People's Hospital
Guangzhou, Guangdong 510080
ChinaActive - Recruiting
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong 510120
ChinaSite Not Available
Shenzhen Second People's Hospital
Shenzhen, Guangdong 518037
ChinaActive - Recruiting
Zhongnan Hospital of Wuhan University
Wuhan, Hubei 430071
ChinaActive - Recruiting
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai 200020
ChinaActive - Recruiting
Shanghai Pulmonary Hospital
Shanghai, Shanghai 200433
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.